Insider · CIK 0001300247
Steven H Holtzman
Files at CAMP (Camp4 Therapeutics Corp). First filing -, latest -.
In brief
Steven H Holtzman files SEC Form 4 as director at CAMP (Camp4 Therapeutics Corp). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Steven H Holtzman has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 10, 2026 | CAMP Camp4 Therapeutics Corp | AGrant or award Stock Option (Right to Buy)derivative | +28,000 | $0.00 | $0 | 28,000 | Jun 12, 2026 |
| Jun 25, 2025 | CAMP Camp4 Therapeutics Corp | AGrant or award Stock Option (Right to Buy)derivative | +9,000 | $0.00 | $0 | 9,000 | Jun 27, 2025 |
| Oct 15, 2024 | CAMP Camp4 Therapeutics Corp | CConversion Common Stock | +8,917 | - | - | 108,946 | Oct 15, 2024 |
| Oct 15, 2024 | CAMP Camp4 Therapeutics Corp | CConversion Series A Prime Preferred Stockderivative | -100,014 | - | - | 0 | Oct 15, 2024 |
Questions about Steven H Holtzman
Answered from the filings on this page, as of the latest one.
Is Steven H Holtzman buying or selling?
Steven H Holtzman has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Steven H Holtzman's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Steven H Holtzman has 0.
Where does Steven H Holtzman file Form 4?
Steven H Holtzman has filed Form 4 at CAMP (Camp4 Therapeutics Corp). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.